Drugs & TargetsFree CHMP recommends approval for Bavencio + Axitinib for first-line treatment of advanced RCC September 27, 2019Vol.45 No.36
Drugs & TargetsFree Celsius Therapeutics brings genomics platform to three institutions worldwide September 27, 2019Vol.45 No.36
Drugs & TargetsFree Foundation Medicine, Natera to advance personalized cancer monitoring September 27, 2019Vol.45 No.36
Drugs & TargetsFree Adaptive Biotechnologies, Amgen use clonoSEQ as preferred MRD test September 27, 2019Vol.45 No.36
Clinical RoundupFree Breast cancer patients who exercise pre-diagnosis are at lower risk for heart disease September 27, 2019Vol.45 No.36
Clinical RoundupFree One in five young adults regularly uses e-cigarettes and believes they are harmless, not addictive September 27, 2019Vol.45 No.36
Clinical RoundupFree Univ. of Arizona researchers look to treat neuropathic pain caused by chemotherapy without using opioids. September 27, 2019Vol.45 No.36
FreeIn Brief Fairness to Kids with Cancer Act is introduced in the House September 27, 2019Vol.45 No.36
